Pembrolizumab in Treating Patients With Malignant Mesothelioma

Clinical trial NCT02399371 · COMPLETED

Trial details

NCT number: NCT02399371
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biphasic Mesothelioma Epithelioid Mesothelioma Peritoneal Malignant Mesothelioma Pleural Biphasic Mesothelioma Pleural Epithelioid Mesothelioma Pleural Malignant Mesothelioma Pleural Sarcomatoid Mesothelioma Recurrent Peritoneal Malignant Mesothelioma Recurrent Pleural Malignant Mesothelioma Sarcomatoid Mesothelioma

Start date: 2015-03-31
Primary completion: 2024-08-13
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.